Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MCHX Stock Forecast 2026-2027
$1.54
Current Price
$73.77M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MCHX Price Targets
+159.7%
To High Target of $4.00
+159.7%
To Median Target of $4.00
+159.7%
To Low Target of $4.00
MCHX Price Momentum
-0.6%
1 Week Change
+2.0%
1 Month Change
+4.8%
1 Year Change
-7.2%
Year-to-Date Change
-33.3%
From 52W High of $2.31
+22.2%
From 52W Low of $1.26
📊 TOP ANALYST CALLS
Did MCHX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Marchex is one of their latest high-conviction picks.
Latest MCHX Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, MCHX has a bullish consensus with a median price target of $4.00 (ranging from $4.00 to $4.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $1.54, the median forecast implies a 159.7% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Darren Aftahi at Roth Capital, projecting a 159.7% upside. Conversely, the most conservative target is provided by Darren Aftahi at Roth Capital, suggesting a 159.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MCHX Analyst Ratings
1
Buy
0
Hold
0
Sell
MCHX Price Target Range
Low
$4.00
Average
$4.00
High
$4.00
Current: $1.54
Latest MCHX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MCHX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 28, 2021 | Roth Capital | Darren Aftahi | Buy | Maintains | $4.00 |
| Jan 28, 2019 | Roth Capital | Buy | Upgrade | $7.00 | |
| Aug 10, 2016 | Roth Capital | Neutral | Downgrade | $N/A | |
| Dec 21, 2015 | Roth Capital | Buy | Initiates | $N/A | |
| Jun 30, 2015 | HC Wainwright & Co. | Equal-Weight | Downgrade | $N/A | |
| Jun 30, 2015 | H.C. Wainwright | Equal-Weight | Downgrade | $N/A | |
| Sep 19, 2014 | BMO Capital | Market Perform | Downgrade | $5.00 | |
| May 2, 2014 | Deutsche Bank | Buy | Maintains | $14.00 | |
| Apr 7, 2014 | Deutsche Bank | Buy | Initiates | $N/A | |
| Nov 7, 2013 | BMO Capital | Outperform | Maintains | $11.00 | |
| Nov 5, 2013 | Northland Securities | Outperform | Initiates | $N/A | |
| Nov 5, 2013 | Northland Capital Markets | Outperform | Initiates | $N/A | |
| Oct 29, 2013 | Stephens & Co. | Overweight | Initiates | $N/A | |
| Aug 7, 2013 | RBC Capital | Outperform | Upgrade | $8.00 | |
| Aug 3, 2012 | Craig-Hallum | Hold | Downgrade | $N/A |
Marchex Inc. (MCHX) Competitors
The following stocks are similar to Marchex based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Marchex Inc. (MCHX) Financial Data
Marchex Inc. has a market capitalization of $73.77M with a P/E ratio of -14.1x. The company generates $45.42M in trailing twelve-month revenue with a -11.5% profit margin.
Revenue growth is -9.0% quarter-over-quarter, while maintaining an operating margin of -9.5% and return on equity of -16.7%.
Valuation Metrics
Market Cap
$73.77M
Enterprise Value
$56.47M
P/E Ratio
-14.1x
PEG Ratio
-0.6x
Price/Sales
1.5x
Growth & Margins
Revenue Growth (YoY)
-9.0%
Gross Margin
+61.2%
Operating Margin
-9.5%
Net Margin
-11.5%
EPS Growth
-9.0%
Financial Health
Cash/Price Ratio
+14.7%
Current Ratio
2.4x
Debt/Equity
2.4x
ROE
-16.7%
ROA
-6.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Marchex Inc. (MCHX) Business Model
About Marchex Inc.
What They Do
Provides data-driven digital advertising solutions.
Business Model
Marchex generates revenue by offering marketing analytics and optimization services to businesses. Its product offerings, including call tracking and conversational intelligence, allow clients to analyze consumer interactions and improve their marketing strategies, thereby enhancing customer engagement and advertising effectiveness.
Additional Information
Founded in 2003 and based in Seattle, Marchex primarily serves industries such as automotive, telecommunications, travel, and insurance. The company plays a crucial role in the digital marketing ecosystem, helping businesses navigate the complexities of customer interactions and adapt to changing consumer expectations.
Company Information
Sector
Communication Services
Industry
Advertising Agencies
Employees
139
CEO
Country
United States
IPO Year
2004
Website
www.marchex.comMarchex Inc. (MCHX) Latest News & Analysis
Latest News
Quick Summary
Marchex (NASDAQ: MCHX) launched the Marchex Engage Platform™, an AI-driven tool for businesses to enhance conversation analytics and boost revenue growth, now available to all customers.
Why It Matters
Marchex's new AI-driven platform enhances conversation analytics, potentially boosting client revenues and market competitiveness, which may lead to increased investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Marchex, Inc. (MCHX) held its Q4 2025 earnings call, discussing financial performance and outlook. Details on revenue, profits, and strategic initiatives were shared.
Why It Matters
The Q4 2025 earnings call for Marchex, Inc. provides insights into financial performance, growth strategies, and market trends, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Marchex Announces Fourth Quarter and Full Year 2025 Results and Archenia Transaction Update
23 days ago
Quick Summary
Marchex, Inc. (NASDAQ: MCHX) reported Q4 2025 GAAP revenue of $10.8 million, down from $11.9 million in Q4 2024. Full year revenue was $45.4 million.
Why It Matters
Marchex's declining revenue signals potential challenges in growth and profitability, impacting investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Marchex (MCHX) reported a quarterly loss of $0.04 per share, worse than the expected loss of $0.01 and compared to a loss of $0.03 per share the previous year.
Why It Matters
Marchex's larger-than-expected quarterly loss signals potential operational issues, which may lead to negative investor sentiment and impact stock performance.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Marchex (NASDAQ: MCHX) launched a new integration with Freshpaint, enhancing AI-driven insights for healthcare marketers while ensuring compliance with regulatory standards.
Why It Matters
Marchex's new integration with Freshpaint enhances its AI offerings in healthcare, potentially increasing market share and driving revenue growth in a lucrative sector, which may positively impact stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Marchex to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 25, 2026
1 month ago
Quick Summary
Marchex (NASDAQ: MCHX) will release its Q4 and full-year financial results for 2025 on March 25, 2026, at 4:20 p.m. ET, available on their corporate website.
Why It Matters
Marchex's upcoming financial results could impact stock performance, providing insights into its growth and AI strategy, which may influence investor sentiment and valuation.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About MCHX Stock
What is Marchex Inc.'s (MCHX) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Marchex Inc. (MCHX) has a median price target of $4.00. The highest price target is $4.00 and the lowest is $4.00.
Is MCHX stock a good investment in 2026?
According to current analyst ratings, MCHX has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.54. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MCHX stock?
Wall Street analysts predict MCHX stock could reach $4.00 in the next 12 months. This represents a 159.7% increase from the current price of $1.54. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Marchex Inc.'s business model?
Marchex generates revenue by offering marketing analytics and optimization services to businesses. Its product offerings, including call tracking and conversational intelligence, allow clients to analyze consumer interactions and improve their marketing strategies, thereby enhancing customer engagement and advertising effectiveness.
What is the highest forecasted price for MCHX Marchex Inc.?
The highest price target for MCHX is $4.00 from Darren Aftahi at Roth Capital, which represents a 159.7% increase from the current price of $1.54.
What is the lowest forecasted price for MCHX Marchex Inc.?
The lowest price target for MCHX is $4.00 from Darren Aftahi at Roth Capital, which represents a 159.7% increase from the current price of $1.54.
What is the overall MCHX consensus from analysts for Marchex Inc.?
The overall analyst consensus for MCHX is bullish. Out of 2 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $4.00.
How accurate are MCHX stock price projections?
Stock price projections, including those for Marchex Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 17, 2026 10:29 PM UTC